JP Morgan Private Wealth Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-9,098
Closed -$260K 1554
2018
Q4
$260K Hold
9,098
﹤0.01% 1237
2018
Q3
$254K Hold
9,098
﹤0.01% 1382
2018
Q2
$254K Hold
9,098
﹤0.01% 1272
2018
Q1
$226K Hold
9,098
﹤0.01% 1149
2017
Q4
$220K Hold
9,098
﹤0.01% 1159
2017
Q3
$251K Sell
9,098
-430
-5% -$11.5K ﹤0.01% 1085
2017
Q2
$239K Buy
9,528
+1,430
+18% +$35.4K ﹤0.01% 1091
2017
Q1
$217K Buy
8,098
+451
+6% +$12.5K ﹤0.01% 1207
2016
Q4
$200K Sell
7,647
-4,050
-35% -$100K ﹤0.01% 1169
2016
Q3
$292K Hold
11,697
﹤0.01% 997
2016
Q2
$254K Hold
11,697
﹤0.01% 1050
2016
Q1
$175K Buy
+11,697
New +$196K ﹤0.01% 1106
2014
Q2
Sell
-10,720
Closed -$137K 937
2014
Q1
$137K Buy
+10,720
New +$140K ﹤0.01% 836

Other funds holding NXTM

JP Morgan Private Wealth Advisors's NXTM Position: Q1 2019 in Review

JP Morgan Private Wealth Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 9,098 shares — an estimated $260K sold.

JP Morgan Private Wealth Advisors first reported a position in NXTM in Q1 2014 and held it in 13 quarters. The position peaked at $292K in Q3 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • JP Morgan Private Wealth Advisors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 9,098 NxStage Medical Inc. shares in Q1 2019, an estimated $260K.
  • JP Morgan Private Wealth Advisors first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 13 quarters.
  • JP Morgan Private Wealth Advisors's NxStage Medical Inc. position peaked at $292K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.